A recent review in Medicina highlights the promising role of sodium-glucose cotransporter 2 inhibitors (SGLT2-i) in diabetic foot prevention, presenting a detailed analysis of their physiological impact and potential benefits. Diabetic foot ulcers and related complications remain significant challenges, contributing to high healthcare costs and morbidity. SGLT2-i, originally developed for blood glucose management in diabetes,... Continue Reading →